Join the 200th Anniversary Celebration

Original Article

Brief Report

Organic Osmolytes in the Brain of an Infant with Hypernatremia

Jung Hee Lee, Edgardo Arcinue, and Brian D. Ross

N Engl J Med 1994; 331:439-442August 18, 1994

Article

Neurologic symptoms due to electrolyte disorders are common, occurring in patients with diarrhea, diabetes mellitus, head injury, renal failure, and many other disorders, especially in infants and the elderly. The clinical syndromes of dehydration and overhydration, often first detected in measurements of plasma sodium or osmolality, are among the most frequent causes of the neurologic symptoms, which include irritability, seizures, lethargy, and coma. There are multiple hormonal and neurogenic mechanisms to maintain total body water and the concentration of solutes (osmolality) within narrow limits. Interruption of these homeostatic mechanisms leads to the retention or loss of either water or solute; the result may be overhydration (with hypo-osmolality) or dehydration (with hyperosmolality). Neurologic function may be impaired in both hypo-osmolar and hyperosmolar states. Forty to 60 percent of children with severe hypernatremia (defined as a plasma sodium concentration ≥ 160 mmol per liter) have neurologic symptoms, as do a majority of patients with hyponatremia (plasma sodium concentration <120 mmol per liter). The mortality rate in patients with severe hypernatremia is as high as 50 to 60 percent1.

Rapid cerebral dehydration can rupture the blood vessels connecting the brain to the rigid calvarium. As a protective mechanism, the brain appears to generate new intracellular solute (sometimes called “idiogenic osmoles”)2. Osmoles (or osmolytes) are volume-regulatory organic solutes that can accumulate to a high concentration within cells, without adverse effects on cellular structure or function. Intracellular osmolality is thereby increased, minimizing the loss of intracellular brain water. A corollary of this process is the clinical observation that overly rapid correction of hyperosmolar states can be fatal. As extracellular fluid is replaced, the increase in intracellular water associated with idiogenic osmoles can lead, it is presumed, to cerebral edema. The rates of accumulation or removal of the idiogenic osmoles are unknown, so that treatment of patients with hyperosmolal and hypo-osmolal states is empirical.

The concept of idiogenic osmoles has recently received support from the identification of several metabolites that are also putative organic osmoles -- myo-inositol, N-acetylaspartate, choline (including glycerophosphoryl choline), and taurine -- in the brains of laboratory animals3,4. The most important of these compounds can be quantified with proton nuclear magnetic resonance (NMR) spectroscopy in the brains of humans in vivo5. We describe here a patient with severe dehydration in whom myo-inositol and other substances accumulated and may have functioned as osmolytes, accounting for the presenting neurologic syndrome and slow recovery from hypernatremia.

Methods

Patient

An 18-month-old girl presented with severe dehydration and hypernatremia (plasma sodium concentration, 195 mmol per liter). The child had not been drinking and was lethargic but otherwise normal. During the correction of dehydration with intravenous glucose plus 0.45 percent sodium chloride, the child's plasma sodium concentration decreased progressively to 144 mmol per liter in three days. Her lethargy diminished, but she had two seizures. The rate of fluid replacement was then reduced. The child's condition improved, she had no further seizures, and she was alert at discharge after 24 days.

Magnetic resonance imaging (MRI) and proton NMR spectroscopy of the cerebral cortex were performed 4, 7, 12, 22, and 36 days after admission to the hospital. The plasma sodium concentration was 156 mmol per liter on day 4 and 140 mmol per liter on day 36.

The proton NMR spectroscopy and MRI studies were approved by the local institutional review board, and written informed consent was obtained from the child's parents and those of normal control subjects of similar age.

Proton NMR Spectroscopy

After MRI, quantitative proton NMR spectroscopy was performed in the parietal and occipital regions of the patient's cerebral cortex, containing primarily white matter and gray matter, respectively. Spectra from the same regions in 50 normal infants were also acquired. The water content of the brain and the volume of cerebrospinal fluid were evaluated by measuring the large difference in T2 transverse relaxation time between them with a quantitative assay described in detail elsewhere6. Subsequent studies of the patient were performed in the same region of the occipital cortex with use of a single axial MRI sequence to verify the location. The images and proton spectra were acquired with a conventional 1.5-T Signa General Electric magnetic resonance scanner.

The first study, performed four days after admission, was obtained from a 12-ml volume of tissue situated across the midline in the gray matter of the occipital cortex and a region of largely white matter in the posterior parietal cortex, with a stimulated echo sequence, a repetition time of 3.0 seconds (and also of 1.5 and 5.0 seconds), an echo time of 30 msec, and a mixing time of 13.7 msec, with 64 repetitions. Quantitation, performed according to the method of Ernst et al.6 and Kreis et al.,7 was confirmed by the determination of the transverse relaxation times (T1 and T2) of the patient's principal cerebral metabolites. The patient's T1 and T2 relaxation times did not differ from those of normal infants8.

Difference spectroscopy, which consists of subtracting the spectra obtained at successive examinations, after scaling them to their appropriate absolute peak intensities,8 was performed for the identification of metabolites. The amount of excess organic osmolytes (idiogenic osmoles) was calculated as the total amount of myo-inositol, choline, creatine, glutamine, and N-acetylaspartate less the mean values obtained for these substances in 50 normal infants8. The excess of each metabolite in the patient could then be calculated and expressed in millimoles or milliosmoles per kilogram.

Results

MRI revealed partial holoprosencephaly, with a normal pituitary stalk but no cerebral edema or tumor. Proton NMR spectroscopy of occipital gray matter (Figure 1Figure 1Short-Echo-Time Proton NMR Spectrum of Cortical Gray Matter in an Infant with Severe Dehydration.) and parietal white matter (not shown) revealed several striking abnormalities. The principal abnormality was a reversal of the normal ratio of peak intensities between the neuronal metabolite N-acetylaspartate and the putative osmolyte myo-inositol. The ratio of N-acetylaspartate to myo-inositol (normally approximately 2.33)8 was only 0.3 when this infant was first studied. In addition, the ratios of choline, glutamine (plus glutamate), and scyllo-inositol (or taurine) to creatine were increased, whereas the ratio of N-acetylaspartate to creatine was reduced. The relaxation values for the metabolites, which if altered by disease can contribute to differences in spectra, did not differ from those in normal infants. The explanation for the changing metabolite ratios became clear after quantitative procedures involving proton NMR spectroscopy were applied6,7. The principal change was in the concentration of myo-inositol, which was three times normal, whereas that of N-acetylaspartate was normal or only minimally reduced as compared with the concentration in an age-matched normal subject. Concentrations of choline and glutamine (plus glutamate) were also increased.

The sequential spectra obtained during correction of the dehydration are shown in Figure 2Figure 2Changes in the Concentrations of Principal Cerebral Organic Osmolytes during the Correction of Severe Dehydration.. The myo-inositol concentration fell progressively, as did those of choline and creatine. The concentration of N-acetylaspartate increased slightly, then returned to normal. The negative peaks in the difference spectra indicate metabolites that were lower in concentration after treatment. The water content of the brain (84 percent on day 4 and 82 percent on day 12) and the T2 relaxation time for water were normal for age8.

The calculated concentrations of the five principal metabolites shown in spectra of the infant's brain (myo-inositol, choline, creatine, glutamine, and N-acetylaspartate) on days 4 to 36 are shown in Table 1Table 1Results of Clinical Proton NMR Spectroscopy for Cerebral Osmometry of the Brain of an Infant with Hypernatremia and Normal Subjects.. The concentration of myo-inositol on day 4 was three times higher than that in normal subjects of the same age. Other substances with elevated concentrations at that time of measurement were choline, scyllo-inositol, creatine, and glutamine (plus glutamate). These levels all decreased to normal during the 36-day study period. If we assume that myo-inositol and the other organic molecules are the same osmolytes identified in earlier studies in animals (with the exception that scyllo-inositol is found in the human brain, rather than taurine, which is found in rat brain), then the excess intracellular osmotic pressure in the brain can be estimated, both when the child was dehydrated and obtunded and later, after correction. We estimate an excess of 17 mOsm initially, falling to about 6 mOsm after 7 days, and returning to normal only after 36 days. The change in total brain water was not significant (the standard error associated with the method was ±3 percent).

Discussion

Holoprosencephaly is commonly associated with a deficiency of thirst and with dehydration,2,12 leading to hypernatremia and neurologic symptoms. These changes were associated with increased concentrations of osmotically active solute in the brain. We have also found changes in these metabolites in adults13 and children recovering from diabetic ketoacidosis and in patients with hypernatremia and hyponatremia14.

The direct determination of patterns of disordered cerebral organic osmolytes by proton NMR spectroscopy may be valuable in guiding therapy. In the presence of severe changes in intracellular osmolytes in the brain (as in this infant), a much slower correction of the plasma sodium concentration, possibly over a period of 7 to 10 days, may be indicated. Conversely, a normal pattern of cerebral osmolytes may permit the safe and rapid replacement of fluids. Repeating proton NMR spectroscopy after 7 to 10 days, or earlier in the event of seizures, may show that a normal cerebral-osmolyte profile has yet to be achieved and may lead to even slower replacement therapy. Central pontine myelinolysis, a rare but fatal complication of severe hypernatremia, may become predictable and it may be possible to prevent it.

Disorders of cerebral osmotic regulation may be more prevalent than has been hitherto assumed. A simplified procedure for NMR spectroscopy of the brain, automated single-voxel acquisition proton NMR spectroscopy (Probe, General Electric Medical Systems),15 now brings this means of measuring osmolyte accumulation within the scope of any hospital with an MRI scanner of 1.5-T field strength.

Supported by a grant from the L.K. Whittier Foundation, South Pasadena, Calif.

We are indebted to Linda Fisher, M.D., for advice on the medical treatment of this child and to Richard Yadley, M.D., for reading the MRI scans.

Source Information

From the Magnetic Resonance Spectroscopy Unit, Huntington Medical Research Institutes (J.H.L., B.D.R.); and Huntington Memorial Hospital (E.A.) -- both in Pasadena, Calif.

Address reprint requests to Dr. Ross at Huntington Medical Research Institutes, 660 S. Fair Oaks Ave., Pasadena, CA 91105.

References

References

  1. 1

    Fraser CL, Arieff AI. Metabolic encephalopathy associated with water, electrolyte and acid-base disorders. In: Maxwell MH, Kleeman CR, Narins RG, eds. Clinical disorders of fluid and electrolyte metabolism. New York: McGraw-Hill, 1987:1153-69.

  2. 2

    Arieff AI, Kleeman CR. Studies on mechanisms of cerebral edema in diabetic comas: effects of hyperglycemia and rapid lowering plasma glucose in normal rabbits. J Clin Invest 1973;52:571-583
    CrossRef | Web of Science | Medline

  3. 3

    Gullans SR, Verbalis JG. Control of brain volume during hyperosmolar and hypo-osmolar conditions. Annu Rev Med 1993;44:289-301
    CrossRef | Web of Science | Medline

  4. 4

    Lien Y-HH, Shapiro JI, Chan L. Effects of hypernatremia on organic brain osmoles. J Clin Invest 1990;85:1427-1435
    CrossRef | Web of Science | Medline

  5. 5

    Ross BD, ed. Proton spectroscopy in clinical medicine. NMR Biomed 1991;4:47-116
    CrossRef | Web of Science

  6. 6

    Ernst T, Kreis R, Ross BD. Absolute quantitation of water and metabolites in the human brain. Part I: compartments and water. J Magn Reson 1993;102:1-8
    Web of Science

  7. 7

    Kreis R, Ernst T, Ross BD. Absolute quantitation of water and metabolites in the human brain. Part II: metabolite concentrations. J Magn Reson 1993;102:9-19
    CrossRef | Web of Science

  8. 8

    Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993;30:424-437
    CrossRef | Web of Science | Medline

  9. 9

    Michaelis T, Moats RA, Lien Y-HH, Ross BD. Depletion of cerebral inositols in rat and human: a HPLC and 1H MRS study of an animal model. In: Proceedings: 12th meeting of the Society of Magnetic Resonance in Medicine, New York, August 14-20, 1993. Berkeley, Calif.: Society of Magnetic Resonance in Medicine, 1993:437. abstract.

  10. 10

    Moats RA, Lien Y-HH, Filippi D, Ross BD. Decrease in cerebral inositols in rats and humans. Biochem J 1993;295:15-18
    Web of Science | Medline

  11. 11

    Lien Y-HH, Michaelis T, Moats RA, Ross BD. Scyllo-inositol depletion in hepatic encephalopathy. Life Sci 1994;54:1507-1512
    CrossRef | Web of Science | Medline

  12. 12

    Morrison G, Singer I. Hyperosmolar states. In: Maxwell MH, Kleeman CR, Narins RG, eds. Clinical disorders of fluid and electrolyte metabolism. New York: McGraw-Hill, 1987:481-518.

  13. 13

    Kreis R, Ross BD. Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology 1992;184:123-130
    Web of Science | Medline

  14. 14

    Videen J, Michaelis T, Raj AS, Pinto P, Ross BD. Moderate hyponatremia modifies brain metabolism. In: Proceedings: 2nd meeting of the Society of Magnetic Resonance, San Francisco, August 8-12, 1994. Berkeley, Calif.: Society of Magnetic Resonance, 1994:193. abstract.

  15. 15

    Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd RE. Automated single-voxel proton MRS: technical development and multisite verification. Magn Reson Med 1994;31:365-373
    CrossRef | Web of Science | Medline

Citing Articles (55)

Citing Articles

  1. 1

    M.A. Steurer, T.M. Berger. (2011) Infusionstherapie bei Neugeborenen, Säuglingen und Kindern. Der Anaesthesist 60:1, 10-22
    CrossRef

  2. 2

    Outi Heikkilä, Sari Mäkimattila, Marjut Timonen, Per-Henrik Groop, Sami Heikkinen, Nina Lundbom. (2010) Cerebellar Glucose During Fasting and Acute Hyperglycemia in Nondiabetic Men and in Men with Type 1 Diabetes. The Cerebellum 9:3, 336-344
    CrossRef

  3. 3

    Chengqing Fang, Jianhua Mao, Yuwen Dai, Yonghui Xia, Haidong Fu, Yifang Chen, Yaping Wang, Aimin Liu. (2010) Fluid management of hypernatraemic dehydration to prevent cerebral oedema: A retrospective case control study of 97 children in China. Journal of Paediatrics and Child Health 46:6, 301-303
    CrossRef

  4. 4

    Karkal Ravishankar Naik, Aralikatte O. Saroja. (2010) Seasonal postpartum hypernatremic encephalopathy with osmotic extrapontine myelinolysis and rhabdomyolysis. Journal of the Neurological Sciences 291:1-2, 5-11
    CrossRef

  5. 5

    Daniel L. Levin. (2008) Cerebral edema in diabetic ketoacidosis. Pediatric Critical Care Medicine 9:3, 320-329
    CrossRef

  6. 6

    Elke Hattingen, Peter Raab, Kea Franz, Friedhelm E. Zanella, Heinrich Lanfermann, Ulrich Pilatus. (2008) Myo-Inositol: a marker of reactive astrogliosis in glial tumors?. NMR in Biomedicine 21:3, 233-241
    CrossRef

  7. 7

    José M. Pascual, Juan Solivera, Ruth Prieto, Laura Barrios, Pilar López-Larrubia, Sebastian Cerdán, José M. Roda. (2007) Time Course of Early Metabolic Changes following Diffuse Traumatic Brain Injury in Rats as Detected by 1 H NMR Spectroscopy. Journal of Neurotrauma 24:6, 944-959
    CrossRef

  8. 8

    Brian D. Ross. 2007. Hepatic and Other Systemically Induced Encephalopathies: Applications of MRS. .
    CrossRef

  9. 9

    I. Sook Park, S. Young Yoon, J. Yeon Min, Y. Hwue Kim, J. Kok Ko, K. Soo Kim, D. Man Seo, J. Hee Lee. (2006) Metabolic Alterations and Neurodevelopmental Outcome of Infants with Transposition of the Great Arteries. Pediatric Cardiology 27:5, 569-576
    CrossRef

  10. 10

    Osamu Sasaki, Noriaki Hattori, Hajime Nakahama, Noriko Inoue, Satoko Nakamura, Takashi Inenaga, Shigeru Kohno, Tohru Sawada, Yuhei Kawano. (2006) Positive correlations between cerebral choline and renal dysfunction in chronic renal failure. Neuroradiology 48:5, 300-306
    CrossRef

  11. 11

    Soo Wan Kim. (2006) Hypernatemia : Successful Treatment. Electrolyte & Blood Pressure 4:2, 66
    CrossRef

  12. 12

    Angel Moreno-Torres, Jesús Pujol, Carles Soriano-Mas, Joan Deus, Alex Iranzo, Joan Santamaria. (2005) Age-related metabolic changes in the upper brainstem tegmentum by MR spectroscopy. Neurobiology of Aging 26:7, 1051-1059
    CrossRef

  13. 13

    STEPHEN ASHWAL, BARBARA HOLSHOUSER, KAREN TONG, TERESA SERNA, RENATTA OSTERDOCK, MATTHEW GROSS, DANIEL KIDO. (2004) Proton Spectroscopy Detected Myoinositol in Children with Traumatic Brain Injury. Pediatric Research 56:4, 630-638
    CrossRef

  14. 14

    Dieter Hussinger. (2004) Neural control of hepatic osmolytes and parenchymal cell hydration. The Anatomical Record 280A:1, 893-900
    CrossRef

  15. 15

    Stacey A. Sullivan, Barry G. Harmon, P. Thomas Purinton, Craig E. Greene, Leigh E. Glerum. (2003) Lobar holoprosencephaly in a Miniature Schnauzer with hypodipsic hypernatremia. Journal of the American Veterinary Medical Association 223:12, 1783-1787
    CrossRef

  16. 16

    Danny Loveday, Anne M. Heacock, Stephen K. Fisher. (2003) Activation of muscarinic cholinergic receptors enhances the volume-sensitive efflux of myo-inositol from SH-SY5Y neuroblastoma cells. Journal of Neurochemistry 87:2, 476-486
    CrossRef

  17. 17

    Soo Mee Lim, Hye-Young Choi, Jung Soo Suh, Jung Hee Lee, Keun Ho Lim, Dae Chul Suh, Ho Kyu Lee, Tae-Hwan Lim, Young Shin Ra. (2003) Localized 1H-MR Spectroscopy in Moyamoya Disease before and after Revascularization Surgery. Korean Journal of Radiology 4:2, 71
    CrossRef

  18. 18

    Helmut Rumpel, Winston Eng Hoe Lim, Hui Meng Chang, Ling Ling Chan, Gaik Lynn Ho, Meng Cheong Wong, Kim Ping Tan. (2003) Is myo-inositol a measure of glial swelling after stroke? a magnetic resonance study. Journal of Magnetic Resonance Imaging 17:1, 11-19
    CrossRef

  19. 19

    G. Bryan Young. 2003. Hyperglycemia and Coma. , 608-609.
    CrossRef

  20. 20

    Gary L Hedlund. (2002) Neuroradiology of the central nervous system in childhood. Neurologic Clinics 20:4, 965-981
    CrossRef

  21. 21

    Stephen K. Fisher, James E. Novak, Bernard W. Agranoff. (2002) Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. Journal of Neurochemistry 82:4, 736-754
    CrossRef

  22. 22

    Kim M. Cecil, Blaise V. Jones. (2001) Magnetic Resonance Spectroscopy of the Pediatric Brain. Topics in Magnetic Resonance Imaging 12:6, 435-452
    CrossRef

  23. 23

    NICOLA J. ROBERTSON, RACHAEL H. LEWIS, FRANCES M. COWAN, JOANNA M. ALLSOP, SERENA J. COUNSELL, A. DAVID EDWARDS, AND, I. JANE COX. (2001) Early Increases in Brain myo-Inositol Measured by Proton Magnetic Resonance Spectroscopy in Term Infants with Neonatal Encephalopathy. Pediatric Research 50:6, 692-700
    CrossRef

  24. 24

    Chi-Jen Chen. (2001) Serial Proton Magnetic Resonance Spectroscopy in Lesions of Balò Concentric Sclerosis. Journal of Computer Assisted Tomography 25:5, 713-718
    CrossRef

  25. 25

    ROBERT H. van AMERONGEN, ANTHONY C. MORETTA, THEODORE J. GAETA. (2001) Severe hypernatremic dehydration and death in a breast-fed infant. Pediatric Emergency Care 17:3, 175-180
    CrossRef

  26. 26

    Yasumitsu Mizobata, Junichiro Yokota, Tetsuya Matsuoka, Hiroshi Horikawa, Keisuke Nakai, Atsuhisa Fukuda. (2001) Volume Supplementation with Iso-Sodium Solution Prevents Hypernatremia after Head Injury. The Journal of Trauma: Injury, Infection, and Critical Care 50:5, 871-877
    CrossRef

  27. 27

    William M. Brooks, Seth D. Friedman, Charles Gasparovic. (2001) Magnetic Resonance Spectroscopy in Traumatic Brain Injury. Journal of Head Trauma Rehabilitation 16:2, 149-164
    CrossRef

  28. 28

    Carl Bjartmar, Grahame Kidd, Sverre Mrk, Richard Rudick, Bruce D. Trapp. (2000) Neurological disability correlates with spinal cord axonal loss and reducedN-acetyl aspartate in chronic multiple sclerosis patients. Annals of Neurology 48:6, 893-901
    CrossRef

  29. 29

    Nicola J Robertson, Jacob Kuint, Serena J Counsell, Mary A Rutherford, Glyn A Coutts, I. Jane Cox, A. David Edwards. (2000) Characterization of Cerebral White Matter Damage in Preterm Infants Using 1H and 31P Magnetic Resonance Spectroscopy. Journal of Cerebral Blood Flow & Metabolism1446-1456
    CrossRef

  30. 30

    Julie A. Edge. (2000) Cerebral oedema during treatment of diabetic ketoacidosis: are we any nearer finding a cause?. Diabetes/Metabolism Research and Reviews 16:5, 316-324
    CrossRef

  31. 31

    Abdesslem Khiat, Céline Bard, André Lacroix, Julie Rousseau, Yvan Boulanger. (1999) Brain metabolic alterations in Cushing's syndrome as monitored by proton magnetic resonance spectroscopy. NMR in Biomedicine 12:6, 357-363
    CrossRef

  32. 32

    Jung Hee Lee, Dong Wan Seo, Yung-Sang Lee, Sang-Tae Kim, Chi-Woong Mun, Tae-Hwan Lim, Young Il Min, Dong-Jin Suh. (1999) Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve. The American Journal of Gastroenterology 94:8, 2206-2213
    CrossRef

  33. 33

    James E. Novak, R. Scott Turner, Bernard W. Agranoff, Stephen K. Fisher. (1999) Differentiated Human NT2-N Neurons Possess a High Intracellular Content of myo-Inositol. Journal of Neurochemistry 72:4, 1431-1440
    CrossRef

  34. 34

    Kay J. Seymour, Stefan Bluml, Jeri Sutherling, William Sutherling, Brian D. Ross. (1999) Identification of cerebral acetone by1H-MRS in patients with epilepsy controlled by ketogenic diet. Magma: Magnetic Resonance Materials in Physics, Biology, and Medicine 8:1, 33-42
    CrossRef

  35. 35

    M Nikodémová, M.A Greer, C Štrbák. (1999) Hypo-osmolarity stimulates and high sodium concentration inhibits thyrotropin-releasing hormone secretion from rat hypothalamus. Neuroscience 88:4, 1299-1306
    CrossRef

  36. 36

    Thorsten Peters-Regehr, Johannes G. Bode, Ralf Kubitz, Dieter Hussinger. (1999) Organic osmolyte transport in quiescent and activated rat hepatic stellate cells (ito cells). Hepatology 29:1, 173-180
    CrossRef

  37. 37

    R Zimmerman. (1998) Advances in pediatric neuroimaging. Brain and Development 20:5, 275-289
    CrossRef

  38. 38

    Brian D. Ross, Thomas Ernst, Roland Kreis, Luke J. Haseler, Stefan Bayer, Else Danielsen, Stefan Blüml, Truda Shonk, Jennifer C. Mandigo, William Caton, Christopher Clark, Steen W. Jensen, Norman L. Lehman, Edgardo Arcinue, Robert Pudenz, C. Hunter Shelden. (1998) 1H MRS in acute traumatic brain injury. Journal of Magnetic Resonance Imaging 8:4, 829-840
    CrossRef

  39. 39

    Heinz-Peter Schlemmer, Regina Möckel, Alexander Marcus, Frank Hentschel, Christopher Göpel, Georg Becker, Julian Köpke, Friedemann Gückel, Martin H Schmidt, Max Georgi. (1998) Proton magnetic resonance spectroscopy in acute, juvenile anorexia nervosa. Psychiatry Research: Neuroimaging 82:3, 171-179
    CrossRef

  40. 40

    Christian Weik, Ulrich Warskulat, Johannes Bode, Thorsten Peters-Regehr, Dieter Hussinger. (1998) Compatible organic osmolytes in rat liver sinusoidal endothelial cells. Hepatology 27:2, 569-575
    CrossRef

  41. 41

    Brian D. Ross, Stefan Bluml, Robert Cowan, Else Danielsen, Neil Farrow, Rolf Gruetter. (1997) In vivo magnetic resonance spectroscopy of human brain: The biophysical basis of dementia. Biophysical Chemistry 68:1-3, 161-172
    CrossRef

  42. 42

    R. Kreis. (1997) Quantitative localized 1H MR spectroscopy for clinical use. Progress in Nuclear Magnetic Resonance Spectroscopy 31:2-3, 155-195
    CrossRef

  43. 43

    M. Zampolini, R. Tarducci, G. Gobbi, M. Franceschini, E. Todeschini, O. Presciutti. (1997) Localized in vivo H-MRS of traumatic brain injury. European Journal of Neurology 4:3, 246-254
    CrossRef

  44. 44

    Stefan Bluml, J. Gordon McComb, Brian D. Ross. (1997) Differentiation between cortical atrophy and hydrocephalus using1H MRS. Magnetic Resonance in Medicine 37:3, 395-403
    CrossRef

  45. 45

    S. Narayanan, L. Fu, E. Pioro, N. De Stefano, D. L. Collins, G. S. Francis, J. P. Antel, P. M. Matthews, D. L. Arnold. (1997) Imaging of axonal damage in multiple sclerosis: Spatial distribution of magnetic resonance imaging lesions. Annals of Neurology 41:3, 385-391
    CrossRef

  46. 46

    W. P. Tormey. (1997) Are the increasing clinical demands for osmolality measurements and their associated electrolytes appropriate?. Irish Journal of Medical Science 166:2, 75-79
    CrossRef

  47. 47

    Brian D. Ross, Stefan Blüml. (1996) New aspects of brain physiology. NMR in Biomedicine 9:7, 279-296
    CrossRef

  48. 48

    Thomas Michaelis, John S. Videen, Michael S. Linsey, Brian D. Ross. (1996) Dialysis and transplantation affect cerebral abnormalities of end-stage renal disease. Journal of Magnetic Resonance Imaging 6:2, 341-347
    CrossRef

  49. 49

    Epstein, Franklin H., , McManus, Michael L., Churchwell, Kevin B., Strange, Kevin, . (1995) Regulation of Cell Volume in Health and Disease. New England Journal of Medicine 333:19, 1260-1267
    Full Text

  50. 50

    Nicola De Stefano, Paul M. Matthews, Douglas L. Arnold. (1995) Reversible decreases inN-acetylaspartate after acute brain injury. Magnetic Resonance in Medicine 34:5, 721-727
    CrossRef

  51. 51

    Howard Trachtman, Paul H. Yancey, Steven R. Gullans. (1995) Cerebral cell volume regulation during hypernatremia in developing rats. Brain Research 693:1-2, 155-162
    CrossRef

  52. 52

    Truda Shonk, Brian D. Ross. (1995) Role of Increased Cerebralmyo-Inositol in the Dementia of Down Syndrome. Magnetic Resonance in Medicine 33:6, 858-861
    CrossRef

  53. 53

    Juan Cordoba, Andres T. Blei. (1995) Cerebral edema and intracranial pressure monitoring. Liver Transplantation and Surgery 1:3, 187-194
    CrossRef

  54. 54

    Ognen A.C. Petroff, Lisa A. Pleban, Dennis D. Spencer. (1995) Symbiosis between in vivo and in vitro NMR spectroscopy: The creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain. Magnetic Resonance Imaging 13:8, 1197-1211
    CrossRef

  55. 55

    (1994) Organic Osmolytes in the Brain of an Infant with Hypernatremia. New England Journal of Medicine 331:26, 1776-1777
    Full Text

Letters